Podcast

James Matera, DO, on the Renoprotective Effects of SGLT2 Inhibitors in DKD

01/13/2020

Dr Matera reviews recent evidence that has demonstrated the potential renal protection offered by sodium glucose co-transporter 2 inhibitors against diabetic kidney disease.

James Matera, DO, FACOI, is a practicing nephrologist, Senior Vice President for Medical Affairs, and Chief Medical Officer at CentraState Medical Center in Freehold, New Jersey.

References:

  1. HHS launches President Trump’s “advancing American kidney health” initiative [press release]. July 10, 2019. https://www.hhs.gov/about/news/2019/07/10/hhs-launches-president-trump-advancing-american-kidney-health-initiative.html.
  2. Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Eng J Med. 2019;380:2295-2306. doi:10.1056/NEJMoa1811744.
  3. Tuttle KR, Lakshmanan MC, Rayner B, et al. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial. Lancet Diabetes Endocrinol. 2018;6(8):605-617. https://doi.org/10.1016/S2213-8587(18)30104-9.
  4. Walther CP, Richardson P, Winkelmayer WC, et al. ACEi/ARB discontinuation and adverse outcomes in CKD. Presented at: American Society of Nephrology 2019 Kidney Week; November 7, 2019 Washington, DC.

Related Content

HIV Management
HIV Management
J. Victor Garcia, MD, on How HIV Infects the Brain
09/21/2018
Dr J. Victor Garcia speaks about his research about how HIV infects the brains of mice and how these results can impact future HIV therapies.
09/21/2018
Cardiovascular Diseases
Cardiovascular Diseases
Laxmi Mehta, MD, on Coronary Disease in Pregnancy
02/28/2019
Dr Laxmi Mehta, from Ohio State University, talks about coronary disease treatments for pregnant women, gives an example of a challenging patient case, and elaborates on the role of statins in the treatment...
02/28/2019
Rheumatology
Rheumatology
Chelsey J. Forbess Smith, MD, on Anakinra Use in Pregnancy
08/07/2018
Chelsey J. Forbess Smith, MD, from Cedars-Sinai Medical Center talks about autoimmune disease outcomes in pregnancies exposed to anakinra before, during, and after birth.
08/07/2018
Hormones
Hormones
Susan Davis, PhD, on the New Consensus Statement on Testosterone Use in Women
01/09/2022
International Menopause Society President Susan Davis, PhD, discusses key points from the latest consensus statement on the use of testosterone therapy in women. The statement has been endorsed by various...
01/09/2022
Cardiovascular Diseases
Cardiovascular Diseases
Andrew Freeman, MD, on Weeding Out the Food Trends for CV Health
09/05/2018
Dr Andrew Freeman from National Jewish Health discusses his latest research: "A Clinician's Guide for Trending Cardiovascular Nutrition Controversies," which was recently published in JACC.
09/05/2018